MedTrace Logo

PCD New Gene Discovery

NCT03801395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-11-25

No results posted yet for this study

Summary

This is a new gene discovery program for individuals with PCD who do not have a specific genetic etiology identified. Research procedures involve a single blood draw from the affected individual and from unaffected family members in an effort to identify new genetic targets.

Conditions

  • Primary Ciliary Dyskinesia

Interventions

OTHER

There is no intervention

No intervention

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-07
Primary Completion
2020-07-01
Completion
2024-11-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03801395 on ClinicalTrials.gov